InsiderTrades

Form 4 for CYTK CYTOKINETICS INC

Accepted 2023-08-11 00:00:00 ET · period of report 2022-12-21 · accession 0001127602-23-022368 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2023-08-11 2022-12-21+ CYTK Blum Robert I Pres, CEO, Dir S - Sale+OE $37.50 -22.5K 406.4K -5% -$843.8K
DM 2023-08-11 2022-12-21+ CYTK Blum Robert I Pres, CEO, Dir M - OptEx $9.59 +22.5K 416.4K +6% +$215.8K
DM 2023-08-11 2022-12-21+ CYTK Blum Robert I Pres, CEO, Dir M - OptEx $0.00 -22.5K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-08-11 S D 792 $32.37 441,417 D — —
2 Common Common Stock 2023-08-11 M A 792 $7.96 442,209 D — —
3 Common Common Stock 2023-08-11 S D 11,708 $32.37 441,417 D — —
4 Common Common Stock 2023-08-11 M A 11,708 $9.65 453,125 D — —
5 Common Common Stock 2022-12-21 S D 10,000 $43.92 406,412 D — —
6 Common Common Stock 2022-12-21 M A 10,000 $9.65 416,412 D — —
7 Derivative Incentive Stock Option (Right to Buy) 2023-08-11 M D 792 $0.00 10,000 D $7.96 · 2015-03-26 to 2025-02-26 792 Common Stock
8 Derivative Non-Qualified Stock Option (Right to Buy) 2022-12-21 M D 10,000 $0.00 155,691 D $9.65 · 2014-03-24 to 2024-02-24 10,000 Common Stock
9 Derivative Incentive Stock Option (Right to Buy) 2023-08-11 M D 11,708 $0.00 0 D $9.65 · 2014-03-24 to 2024-02-24 11,708 Common Stock